When compared to the non-NAFLD group, subjects in the NAFLD group had a significantly higher level of BMI, WC, SBP, DBP, FBG, TC, TG, LDL-C, UA, ALT, AST, and DBIL and lower levels of HDL-C (P < 0.001) (Table 1). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.